Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Li Gobbi

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Rheumatology|August 28, 2018
Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibitionAntonella Fioravanti, Sara Tenti, Maria Romana Bacarelli, et al.
Journal of Personalized Medicine|December 24, 2025
Biopsy-Driven Synovial Pathophenotyping in RA: A New Approach to Personalized TreatmentSheyda Ketabchi, Edda Russo, Maurizio Benucci, et al.
Frontiers in Bioscience (Landmark Edition)|September 4, 2023
Different Biomarkers of Response to Treatment with Selective Jak-1 Inhibitors in Rheumatoid ArthritisMaurizio Benucci, Francesca Li Gobbi, Paola Fusi, et al.
Case Reports in Neurological Medicine|February 29, 2020
Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 AntibodiesMaurizio Benucci, Luciana Tramacere, Maria Infantino, et al.
Journal of Personalized Medicine|December 23, 2022
The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine PerspectiveMaurizio Benucci, Arianna Damiani, Edda Russo, et al.
Antibodies (Basel, Switzerland)|August 22, 2025
Anti-HMGCR-Antibody-Positive Statin-Induced Myositis: A Pilot Case Series on Treatment with Bempedoic Acid and Immunosuppressive TherapyMaurizio Benucci, Riccardo Terenzi, Francesca Li Gobbi, et al.
Immunologic Research|September 16, 2025
Optimizing antiphospholipid antibody testing: a real-world analysis of appropriateness and resource utilizationSilvia Grazietta Foddai, Maria Infantino, Mariangela Manfredi, et al.
Biologics : Targets & Therapy|March 4, 2015
Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulinsMaurizio Benucci, Francesca Li Gobbi, Francesca Meacci, et al.
Immunologic Research|August 29, 2024
Predictive biomarkers of response to tocilizumab in giant cell arteritis (GCA): correlations with imaging activityMaurizio Benucci, Ilaria Di Girolamo, Antonino Di Girolamo, et al.
Clinical and Experimental Rheumatology|April 4, 2020
Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales?Francesca Bandinelli, Maurizio Benucci, Fausto Salaffi, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Rheumatology|August 28, 2018
Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibitionAntonella Fioravanti, Sara Tenti, Maria Romana Bacarelli, et al.
Journal of Personalized Medicine|December 24, 2025
Biopsy-Driven Synovial Pathophenotyping in RA: A New Approach to Personalized TreatmentSheyda Ketabchi, Edda Russo, Maurizio Benucci, et al.
Frontiers in Bioscience (Landmark Edition)|September 4, 2023
Different Biomarkers of Response to Treatment with Selective Jak-1 Inhibitors in Rheumatoid ArthritisMaurizio Benucci, Francesca Li Gobbi, Paola Fusi, et al.
Case Reports in Neurological Medicine|February 29, 2020
Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 AntibodiesMaurizio Benucci, Luciana Tramacere, Maria Infantino, et al.
Journal of Personalized Medicine|December 23, 2022
The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine PerspectiveMaurizio Benucci, Arianna Damiani, Edda Russo, et al.
Antibodies (Basel, Switzerland)|August 22, 2025
Anti-HMGCR-Antibody-Positive Statin-Induced Myositis: A Pilot Case Series on Treatment with Bempedoic Acid and Immunosuppressive TherapyMaurizio Benucci, Riccardo Terenzi, Francesca Li Gobbi, et al.
Immunologic Research|September 16, 2025
Optimizing antiphospholipid antibody testing: a real-world analysis of appropriateness and resource utilizationSilvia Grazietta Foddai, Maria Infantino, Mariangela Manfredi, et al.
Biologics : Targets & Therapy|March 4, 2015
Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulinsMaurizio Benucci, Francesca Li Gobbi, Francesca Meacci, et al.
Immunologic Research|August 29, 2024
Predictive biomarkers of response to tocilizumab in giant cell arteritis (GCA): correlations with imaging activityMaurizio Benucci, Ilaria Di Girolamo, Antonino Di Girolamo, et al.
Clinical and Experimental Rheumatology|April 4, 2020
Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales?Francesca Bandinelli, Maurizio Benucci, Fausto Salaffi, et al.
Pageof 7